Reducing Patient Memory Recall in the Burning Mouth Patient Population

Status Recruiting

Clinical Trial Summary

The goal of this study is to learn about burning mouth syndrome symptoms in real time in patients with burning mouth syndrome. The main questions it aims to answer are: (1) To test the ability of a smartphone app to collect repeated observations of individual data to assess fluctuations in BMS symptoms (pain) at multiple points in the day as they happen; (2) To evaluate a panel of salivary biomarkers in patients with burning mouth syndrome (BMS) and to study their relationship with clinical variables. With a collaboration between Penn Dental Medicine and Wharton School of Business, our proposal aims to vastly improve the characterization of burning mouth syndrome through the use of a smartphone app and/or text-based notification. Participants will attend 2 study visits where they will complete questionnaires and provide saliva samples and will respond to notifications/text message prompts on their smart phone 3 times a day for 12 weeks.

Clinical Trial Description

This is a prospective study with the aims: (1) To test the ability of a smartphone app to collect repeated observations of individual data to assess fluctuations in BMS symptoms (pain) at multiple points in the day as they happen; (2) To evaluate a panel of salivary biomarkers in patients with burning mouth syndrome (BMS) and to study their relationship with clinical variables. Participants will attend 2 study visits. Visit 1 of the study will consist of screening during the baseline visit. It will include administration of questionnaires, informed consent, collection of salivary samples, helping to download the app and/or helping to set up the smartphone to receive text notifications, and assisting with the demonstration of taking surveys on smartphones. Track Your Happiness app, a smartphone and/or text-based notification system to take surveys, will collect data on people's experiences across a random sample of the moments of their lives. Participants will receives notifications 3 times per day at random times, and will be prompted to answer questions related to the burning mouth, to exercise, and a random selection of non-clinical Track Your Happiness questions, e.g., "Are you interacting with anyone right now?" "How do you feel right now?" Participants will receive these notifications for 12 weeks. The final study visit (visit 2) will take place 12 weeks after Visit 1. Visit 2 will consist of questionnaires and collection of salivary samples. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05819697
Study type	Observational [Patient Registry]
Source	University of Pennsylvania
Contact	Eugene Ko, DDS
Phone	215-573-8177
Email	PDMTranslationalMed@dental.upenn.edu
Status	Recruiting
Phase
Start date	March 14, 2023
Completion date	December 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04475614` - Therapeutic Options for Treatment of Burning Mouth Syndrome	N/A
Completed	`NCT00374673` - Efficacy of Transcranial Magnetic Stimulation (TMS) in Chronic Idiopathic Pain Disorders	Phase 3
Completed	`NCT02964728` - Botulinum Toxin in Burning Mouth Syndrome	Phase 2
Completed	`NCT04535973` - Hormonal Status and Quality of Life in Female Postmenopausal Patients With Burning Mouth Syndrome
Recruiting	`NCT06040190` - Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome	Phase 4
Not yet recruiting	`NCT05059418` - Burning Mouth Syndrome - New Diagnostic Criteria and Treatment	N/A
Recruiting	`NCT01867151` - Effect of Gluten Free Diet in Patients With Burning Mouth Syndrome	N/A
Completed	`NCT05872789` - Impact of Diazepam 1% Oral Gel Efficacy in Burning Mouth Syndrome	N/A
Completed	`NCT05871580` - Effect to the Photobiomodulation in the Burning Mouth Syndrome	N/A
Recruiting	`NCT05309070` - The Efficacy of N-acetyl-cysteine in the Treatment of Burning Mouth Syndrome	N/A
Completed	`NCT05399238` - Thermography and Burning Mouth Syndrome
Completed	`NCT02382029` - Acupuncture Versus Clonazepam in Burning Mouth Syndrome	Phase 0
Completed	`NCT02580734` - Efficacy of Melatonin in Burning Mouth Syndrome (BMS)	N/A
Completed	`NCT02757612` - Study Evaluating the Laser Diode Effect Burning Mouth Syndrome	N/A
Completed	`NCT00862576` - A Study of the Association of Sleep Dysfunction and Burning Mouth Syndrome	N/A
Not yet recruiting	`NCT04189367` - Treatment of Burning Mouth Syndrome With Integration of Traditional Chinese Medicine and Western Medicine	Phase 3
Completed	`NCT00001524` - Thalidomide to Treat Oral Lesions in HIV-Infected Patients	Phase 2
Recruiting	`NCT04481841` - Head Yuanshi Dian Therapy in Burning Mouth Syndrome	Early Phase 1
Completed	`NCT02686359` - Opiorphin Levels in Fluids of Burning Mouth Syndrome Patients (OPIODYN)	N/A
Completed	`NCT05309681` - Salivary Melatonin Levels and Sleep Quality in Patients With Burning Mouth Syndrome

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.